Chest
PULMONARY VASCULAR DISEASE: THE GLOBAL PERSPECTIVESchistosomiasis-Associated Pulmonary Hypertension: Pulmonary Vascular Disease: The Global Perspective
Section snippets
Case Presentation
The patient was a woman aged 31 years when she presented at Procape Hospital in Recife, the capital of the State of Pernambuco in northeast Brazil. She had a history of multiple unexplained syncopal episodes beginning at age 17. At the time of presentation, she complained of significant progressive shortness of breath with minimal exertion (World Health Organization functional class III), palpitations, and intermittent chest pain. She had never smoked or used anorexigens. She was born and grew
The Global Impact of Schistosomiasis
Schistosomiasis is the third most common parasitic disease after malaria and amebiasis, affecting about 200 to 300 million people in 74 countries, 85% of whom live in sub-Saharan Africa. Almost 500 to 800 million people are at risk for acquiring the infection that accounts for > 250,000 deaths per year. It causes up to 4.5 million disability-adjusted life year losses annually due to factors such as anemia, pain, diarrhea, exercise intolerance, and undernutrition that results from chronic
Schistosome, the Parasite
Schistosomiasis is an ancient and chronic disease of humans, nonhuman primates, other mammals, and birds. It is also known as bilharzia, or snail fever, and is caused by several species of the genus Schistosoma. These parasites are flatworm flukes of the trematoda class. The main species to infect humans is Schistosoma mansoni (also known as Manson blood fluke or swamp fever). The worm has two hosts in its life cycle (Fig 217) and involves many steps.18, 19 Snails of the Biomphalaria genus are
Acute Schistosomiasis Infection
After penetration, the cercariae may remain in the skin for 1 to 2 days. At the site of penetration, the parasite leaves behind an itchy punctate rash, called cercarial dermatitis, that self-resolves after the parasite leaves. The cercaria accesses the bloodstream through the postcapillary venules and undergoes transformation into schistosomulum prior to becoming an adult worm. Migration through the venous system continues, and the parasite reaches the lungs. At this stage, schistosomiasis
Portal Fibrosis: A Potential Precursor to Chronic Pulmonary Disease
A minority of the eggs released by the reproducing adult worms remain within the host. For S mansoni and S japonicum, the retained ova remain within the portal venous system, either in the intestinal mucosa or in the small portal veins within the liver. Within the liver, the ova become niduses for periovular epitheloid granulomatous reactions as the immune system attempts to encapsulate the parasite. Although these lesions result in eventual egg destruction, they also lead to tissue destruction
Pulmonary Periovular Granulomas and Vascular Remodeling: What Is the Link?
In patients with portal hypertension, Schistosoma eggs embolize into the lungs where they lodge in small muscular arteries and induce isolated granulomas. Andrade and Andrade41 reported that among 78 persons with hepatosplenic schistosomiasis, 72% had periovular granulomas. One-third had numerous periovular granulomas involving the alveolar tissue and the pulmonary arterioles. The cellular components of the pulmonary granulomas include eosinophils, macrophages, leukocytes, and fibroblasts as
PH and Schistosomiasis-Specific Treatment Options
It is apparent that schistosomiasis relies on persistent, recurrent, high-egg-burden chronic infection. The cycle can be interrupted with sanitation and education measures to prevent fresh water exposure to infectious cercariae. However, several cultural and economic hurdles prevent the successful implementation of these preventive measures. These difficulties underlie the global impact of schistosomiasis. Furthermore, patients with recurrent hemoptysis due to hepatosplenic disease in
Acknowledgments
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Bandeira has received speaking fees from Pfizer. Dr Butrous owns Shares in Pfizer Ltd and has participated in speaking activities and industry advisory committees. Drs Graham, Bandeira, Morrell, Butrous, and Tuder have disclosed that they are affiliated with the Pulmonary Vascular Research Institute.
References (62)
- et al.
Pathology of pulmonary hypertension
Clin Chest Med
(2007) - et al.
The global status of schistosomiasis and its control
Acta Trop
(2000) - et al.
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
Lancet
(2005) - et al.
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk
Lancet Infect Dis
(2006) - et al.
Making sense of the schistosome surface
Adv Parasitol
(2006) - et al.
Human schistosomiasis
Lancet
(2006) Schistosomiasis (bilharziasis): from antiquity to the present
Infect Dis Clin North Am
(2004)- et al.
Developmental plasticity in schistosomes and other helminths
Int J Parasitol
(2003) Pulmonary schistosomiasis
Clin Chest Med
(2002)- et al.
Hepatosplenic schistosomiasis. Pathophysiology and treatment
Gastroenterol Clin North Am
(1992)
Updated clinical classification of pulmonary hypertension
J Am Coll Cardiol
Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension
Biochem Pharmacol
Towards an understanding of the mechanism of action of praziquantel
Mol Biochem Parasitol
Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies
Acta Trop
Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines
Chest
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Lancet
Inflammation in pulmonary arterial hypertension
Eur Respir J
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
Arthritis Rheum
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
Am J Pathol
Schistosomiasis
Nat Rev Microbiol
Schistosomiasis—a century searching for chemotherapeutic drugs
Parasitol Res
Drug discovery: schistosome treatment
Nature
Drugs for treating urinary schistosomiasis
Cochrane Database Syst Rev
Schistosoma haematobium (Egyptian strain): rate of development and effect of praziquantel treatment
J Parasitol
Praziquantel
Parasitol Res
Large water management projects and schistosomiasis control, Dongting Lake region, China
Emerg Infect Dis
Effect of the Aswan High Dam on prevalence of schistosomiasis in Egypt
Trop Geogr Med
Three Gorges Dam and its impact on the potential transmission of schistosomiasis in regions along the Yangtze River
EcoHealth
Identification of Parasites of Public Health Concern
Schistosomiasis
Curr Protoc Immunol
Attrition and temporal distribution of Schistosoma mansoni and S. haematobium schistosomula in laboratory mice
Parasitology
Cited by (94)
Vascular Infections in the Thorax
2022, Seminars in RoentgenologyImpact of Pulmonary Arterial Hypertension on Systemic Inflammation, Cardiac Injury and Hemodynamics in Sepsis: A Retrospective Study From MIMIC-III
2022, American Journal of the Medical SciencesPulmonary hypertension
2022, Practical Pulmonary Pathology: A Diagnostic ApproachDoxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection
2021, International ImmunopharmacologyCitation Excerpt :As expected, we developed a consistent model of schistosomiasis, which manifested marked lung accumulation of S. mansoni eggs in the chronic phase of infection. In schistosomiasis, the development of lung granulomatous inflammation is directly linked to the retention of eggs in the pulmonary circulation, which migrates from the portal system to the lung parenchyma from portocaval shunts [52,53]. Thus, eggs trapped in the lungs trigger an intense inflammatory response that drives granulomatous lung disease [52,54], which was consistently associated to reduced weight gain, increased lung mass, intense and diffuse inflammatory infiltrate, vascular congestion, and extensive microstructural lung remodeling evidenced by alveolar collapse, septal thickening, expansion of the connective stroma and tissue fibrosis.
Pulmonary Vascular Disease as a Systemic and Multisystem Disease
2021, Clinics in Chest Medicine
Funding/Support: This work was supported by the Cardiovascular Medical Research Fund.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).